Kathryn Kronquist
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperglycinemia, Nonketotic | 4 | 2023 | 48 | 0.600 |
Why?
| Fragile X Syndrome | 2 | 2021 | 73 | 0.470 |
Why?
| Genetic Testing | 3 | 2021 | 424 | 0.200 |
Why?
| Genetics, Medical | 1 | 2021 | 22 | 0.180 |
Why?
| Aminomethyltransferase | 2 | 2017 | 8 | 0.170 |
Why?
| Warfarin | 2 | 2011 | 150 | 0.160 |
Why?
| Taurine | 1 | 2019 | 41 | 0.160 |
Why?
| Cystathionine beta-Synthase | 1 | 2019 | 69 | 0.150 |
Why?
| Homocystinuria | 1 | 2019 | 70 | 0.150 |
Why?
| Aldehyde Dehydrogenase | 1 | 2019 | 103 | 0.150 |
Why?
| Epilepsy | 2 | 2019 | 314 | 0.140 |
Why?
| Glyceric Acids | 1 | 2017 | 6 | 0.140 |
Why?
| Hyperoxaluria, Primary | 1 | 2017 | 14 | 0.140 |
Why?
| Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.130 |
Why?
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.130 |
Why?
| Myelin Basic Protein | 4 | 1987 | 46 | 0.120 |
Why?
| Fetus | 5 | 1995 | 764 | 0.120 |
Why?
| Glycine | 3 | 2023 | 162 | 0.110 |
Why?
| alpha-Fetoproteins | 2 | 1990 | 39 | 0.100 |
Why?
| Drug Dosage Calculations | 1 | 2011 | 21 | 0.100 |
Why?
| Mixed Function Oxygenases | 1 | 2011 | 37 | 0.100 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 41 | 0.100 |
Why?
| Spinal Cord | 3 | 1987 | 360 | 0.080 |
Why?
| Exons | 3 | 2023 | 330 | 0.080 |
Why?
| Mutation | 4 | 2023 | 3671 | 0.080 |
Why?
| Prenatal Diagnosis | 1 | 1990 | 189 | 0.080 |
Why?
| Trinucleotide Repeats | 1 | 2008 | 26 | 0.080 |
Why?
| Arthroplasty | 1 | 2008 | 54 | 0.070 |
Why?
| Biomarkers | 1 | 2019 | 3874 | 0.070 |
Why?
| Transferases | 2 | 2017 | 33 | 0.070 |
Why?
| Thromboembolism | 1 | 2008 | 105 | 0.070 |
Why?
| Anticoagulants | 1 | 2011 | 622 | 0.070 |
Why?
| Clinical Protocols | 1 | 2008 | 255 | 0.070 |
Why?
| Pharmacogenetics | 1 | 2008 | 170 | 0.070 |
Why?
| Myelin Proteins | 1 | 1987 | 44 | 0.070 |
Why?
| Embryonic and Fetal Development | 1 | 1987 | 95 | 0.070 |
Why?
| Amniotic Fluid | 2 | 1984 | 79 | 0.070 |
Why?
| Guidelines as Topic | 1 | 2008 | 259 | 0.070 |
Why?
| Genotype | 3 | 2019 | 1834 | 0.060 |
Why?
| Gene Expression Regulation | 3 | 1995 | 2520 | 0.060 |
Why?
| Mutation, Missense | 2 | 2017 | 319 | 0.060 |
Why?
| Algorithms | 2 | 2011 | 1626 | 0.060 |
Why?
| Proteins | 2 | 2023 | 945 | 0.060 |
Why?
| Liver | 2 | 1990 | 1832 | 0.060 |
Why?
| Down Syndrome | 1 | 1990 | 454 | 0.060 |
Why?
| Fetal Proteins | 1 | 1984 | 16 | 0.060 |
Why?
| Molecular Probe Techniques | 1 | 2003 | 9 | 0.050 |
Why?
| Proteinuria | 1 | 1984 | 89 | 0.050 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2003 | 35 | 0.050 |
Why?
| Predictive Value of Tests | 1 | 2008 | 1967 | 0.050 |
Why?
| Glycoproteins | 4 | 1986 | 340 | 0.050 |
Why?
| Electrophoresis, Polyacrylamide Gel | 3 | 1990 | 325 | 0.050 |
Why?
| Hepacivirus | 1 | 2003 | 235 | 0.050 |
Why?
| Gestational Age | 4 | 1990 | 857 | 0.050 |
Why?
| Humans | 19 | 2023 | 128896 | 0.040 |
Why?
| Pancreas | 3 | 1978 | 307 | 0.040 |
Why?
| Hepatitis C | 1 | 2003 | 234 | 0.040 |
Why?
| Fragile X Mental Retardation Protein | 1 | 2021 | 55 | 0.040 |
Why?
| Lipoprotein Lipase | 1 | 1980 | 59 | 0.040 |
Why?
| Base Sequence | 5 | 1995 | 2157 | 0.040 |
Why?
| RNA, Viral | 1 | 2003 | 622 | 0.040 |
Why?
| DNA | 4 | 1987 | 1406 | 0.040 |
Why?
| Infant, Premature | 1 | 1984 | 540 | 0.040 |
Why?
| 2-Aminoadipic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| Homocysteine | 1 | 2019 | 150 | 0.040 |
Why?
| Oviducts | 1 | 1978 | 17 | 0.040 |
Why?
| Brachial Artery | 1 | 2019 | 205 | 0.040 |
Why?
| Amino Acid Oxidoreductases | 1 | 2017 | 19 | 0.040 |
Why?
| Heparitin Sulfate | 1 | 1977 | 44 | 0.040 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 41 | 0.030 |
Why?
| Multienzyme Complexes | 1 | 2017 | 69 | 0.030 |
Why?
| Glycosaminoglycans | 1 | 1977 | 85 | 0.030 |
Why?
| Heterozygote | 1 | 2017 | 268 | 0.030 |
Why?
| Homozygote | 1 | 2017 | 192 | 0.030 |
Why?
| Point Mutation | 1 | 2017 | 226 | 0.030 |
Why?
| Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.030 |
Why?
| Genomics | 1 | 2021 | 715 | 0.030 |
Why?
| Female | 9 | 2021 | 68162 | 0.030 |
Why?
| Introns | 1 | 2016 | 242 | 0.030 |
Why?
| Myocardium | 1 | 1980 | 981 | 0.030 |
Why?
| Blotting, Northern | 2 | 1995 | 202 | 0.030 |
Why?
| Carrier Proteins | 2 | 2017 | 728 | 0.030 |
Why?
| DNA, Complementary | 1 | 1995 | 270 | 0.030 |
Why?
| Male | 9 | 2019 | 63146 | 0.030 |
Why?
| Genetic Carrier Screening | 1 | 1993 | 25 | 0.030 |
Why?
| Molecular Weight | 5 | 1987 | 332 | 0.030 |
Why?
| Chromosome Mapping | 1 | 1995 | 503 | 0.030 |
Why?
| Biochemistry | 1 | 1993 | 39 | 0.030 |
Why?
| Alleles | 1 | 2016 | 847 | 0.030 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 210 | 0.030 |
Why?
| United States | 2 | 2021 | 13975 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2017 | 1435 | 0.030 |
Why?
| Oxidative Stress | 1 | 2019 | 1220 | 0.030 |
Why?
| Infant, Newborn | 1 | 1984 | 5704 | 0.020 |
Why?
| Vitamin K Epoxide Reductases | 1 | 2011 | 12 | 0.020 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2011 | 20 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 1995 | 2842 | 0.020 |
Why?
| Blood Proteins | 2 | 1984 | 233 | 0.020 |
Why?
| International Normalized Ratio | 1 | 2011 | 47 | 0.020 |
Why?
| Hematopoietic Stem Cells | 1 | 1995 | 378 | 0.020 |
Why?
| Education, Medical, Undergraduate | 1 | 1993 | 174 | 0.020 |
Why?
| Amino Acid Sequence | 3 | 1995 | 2047 | 0.020 |
Why?
| Premedication | 1 | 2008 | 40 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2011 | 641 | 0.020 |
Why?
| Inflammation | 1 | 2019 | 2694 | 0.020 |
Why?
| Models, Statistical | 1 | 2011 | 626 | 0.020 |
Why?
| Proteolipids | 1 | 1987 | 30 | 0.020 |
Why?
| Transcription Factors | 1 | 1995 | 1634 | 0.020 |
Why?
| Myelin Proteolipid Protein | 1 | 1987 | 62 | 0.020 |
Why?
| RNA, Messenger | 3 | 1995 | 2700 | 0.020 |
Why?
| Clathrin | 1 | 1986 | 26 | 0.020 |
Why?
| Adult | 4 | 2019 | 35361 | 0.020 |
Why?
| Treatment Outcome | 2 | 2011 | 10239 | 0.020 |
Why?
| Organoids | 1 | 1986 | 100 | 0.020 |
Why?
| Pregnancy | 2 | 1990 | 6247 | 0.010 |
Why?
| Rats | 4 | 1986 | 5236 | 0.010 |
Why?
| Membrane Proteins | 3 | 1986 | 1100 | 0.010 |
Why?
| Immunosorbent Techniques | 1 | 1984 | 18 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1984 | 34 | 0.010 |
Why?
| RNA | 1 | 1990 | 877 | 0.010 |
Why?
| Mucoproteins | 1 | 1984 | 10 | 0.010 |
Why?
| Kinetics | 2 | 1978 | 1619 | 0.010 |
Why?
| beta 2-Microglobulin | 1 | 1984 | 49 | 0.010 |
Why?
| Uromodulin | 1 | 1984 | 21 | 0.010 |
Why?
| Cystic Fibrosis | 1 | 1993 | 1061 | 0.010 |
Why?
| Pregnancy Trimester, Second | 1 | 1984 | 73 | 0.010 |
Why?
| Albumins | 1 | 1984 | 102 | 0.010 |
Why?
| Fibronectins | 1 | 1984 | 116 | 0.010 |
Why?
| Serum Albumin | 1 | 1984 | 145 | 0.010 |
Why?
| Young Adult | 1 | 2019 | 12286 | 0.010 |
Why?
| Fetal Blood | 1 | 1984 | 315 | 0.010 |
Why?
| Viral Load | 1 | 2003 | 448 | 0.010 |
Why?
| Animals | 9 | 1995 | 34628 | 0.010 |
Why?
| Immunologic Techniques | 1 | 1980 | 39 | 0.010 |
Why?
| Subcellular Fractions | 2 | 1978 | 80 | 0.010 |
Why?
| Adolescent | 1 | 2019 | 20197 | 0.010 |
Why?
| Cloning, Molecular | 2 | 1995 | 536 | 0.010 |
Why?
| Dietary Carbohydrates | 1 | 1980 | 151 | 0.010 |
Why?
| Child | 1 | 2019 | 20824 | 0.010 |
Why?
| Middle Aged | 2 | 2011 | 30977 | 0.010 |
Why?
| Enzyme Activation | 1 | 1980 | 811 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 1840 | 0.010 |
Why?
| Dietary Fats | 1 | 1980 | 302 | 0.010 |
Why?
| Guanosine Diphosphate Mannose | 1 | 1978 | 1 | 0.010 |
Why?
| Carbachol | 1 | 1977 | 21 | 0.010 |
Why?
| Oligosaccharides | 1 | 1978 | 57 | 0.010 |
Why?
| Prospective Studies | 1 | 2008 | 7060 | 0.010 |
Why?
| Glucose | 1 | 1980 | 976 | 0.010 |
Why?
| Cell Fusion | 1 | 1995 | 51 | 0.010 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 1995 | 47 | 0.010 |
Why?
| Brain | 1 | 1987 | 2592 | 0.010 |
Why?
| Gene Library | 1 | 1995 | 118 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 138 | 0.010 |
Why?
| Risk Factors | 1 | 2008 | 9792 | 0.010 |
Why?
| Genetic Linkage | 1 | 1995 | 298 | 0.010 |
Why?
| Voluntary Programs | 1 | 1993 | 3 | 0.010 |
Why?
| Bone Marrow | 1 | 1995 | 262 | 0.010 |
Why?
| Ethics, Medical | 1 | 1993 | 79 | 0.010 |
Why?
| Cell Fractionation | 2 | 1986 | 55 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1995 | 928 | 0.010 |
Why?
| Leukemia | 1 | 1995 | 228 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 1995 | 778 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 1045 | 0.010 |
Why?
| Aged | 1 | 2008 | 22035 | 0.000 |
Why?
| Mice | 3 | 1995 | 16543 | 0.000 |
Why?
| Membranes | 2 | 1978 | 20 | 0.000 |
Why?
| Cytoplasmic Granules | 2 | 1978 | 82 | 0.000 |
Why?
| Carbohydrates | 2 | 1978 | 62 | 0.000 |
Why?
| Cells, Cultured | 1 | 1995 | 4048 | 0.000 |
Why?
| Coated Pits, Cell-Membrane | 1 | 1986 | 4 | 0.000 |
Why?
| Asialoglycoprotein Receptor | 1 | 1986 | 4 | 0.000 |
Why?
| Isoelectric Point | 1 | 1986 | 23 | 0.000 |
Why?
| Receptor, IGF Type 2 | 1 | 1986 | 7 | 0.000 |
Why?
| Electrophoresis, Agar Gel | 1 | 1986 | 26 | 0.000 |
Why?
| Exocytosis | 1 | 1986 | 89 | 0.000 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1986 | 150 | 0.000 |
Why?
| Microscopy, Electron | 1 | 1986 | 417 | 0.000 |
Why?
| Guinea Pigs | 1 | 1986 | 158 | 0.000 |
Why?
| Endocytosis | 1 | 1986 | 162 | 0.000 |
Why?
| Receptors, Immunologic | 1 | 1986 | 213 | 0.000 |
Why?
| Species Specificity | 1 | 1986 | 566 | 0.000 |
Why?
| Genetic Variation | 1 | 1986 | 935 | 0.000 |
Why?
| Sialic Acids | 1 | 1977 | 8 | 0.000 |
Why?
| Dogs | 1 | 1977 | 372 | 0.000 |
Why?
| Amino Acids | 1 | 1977 | 469 | 0.000 |
Why?
|
|
Kronquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|